We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
976
Roivant Sciences
ROIV
$23.6B
$131K ﹤0.01%
11,637
+40
+0.3% +$390
JKS
977
JinkoSolar
JKS
$764M
$129K ﹤0.01%
3,500
QFIN icon
978
Qfin Holdings
QFIN
$1.68B
$125K ﹤0.01%
7,900
FTDR icon
979
Frontdoor
FTDR
$5.27B
$124K ﹤0.01%
3,528
-1,976
-36% -$65.7K
FDMT icon
980
4D Molecular Therapeutics
FDMT
$502M
$119K ﹤0.01%
5,872
+1,110
+23% +$14.6K
INVZ icon
981
Innoviz Technologies
INVZ
$84.1M
$116K ﹤0.01%
45,713
+16,629
+57% +$31.9K
RXRX icon
982
Recursion Pharmaceuticals
RXRX
$1.58B
$116K ﹤0.01%
11,759
+11,028
+1,509% +$78.6K
ESPR
983
DELISTED
Esperion Therapeutics
ESPR
$115K ﹤0.01%
38,500
-235
-0.6% -$305
IBB icon
984
iShares Biotechnology ETF
IBB
$9.45B
$115K ﹤0.01%
849
-383
-31% -$46.7K
CSIQ icon
985
Canadian Solar
CSIQ
$932M
$113K ﹤0.01%
4,300
TOL icon
986
Toll Brothers
TOL
$14B
$113K ﹤0.01%
+1,100
New +$91.7K
WOLF icon
987
PUT
Wolfspeed
WOLF
$1.04B
$113K ﹤0.01%
1,750
+1,296
+285% +$47K
CCJ icon
988
Cameco
CCJ
$36.8B
$112K ﹤0.01%
+2,600
New +$109K
DUOL icon
989
Duolingo
DUOL
$6.53B
$110K ﹤0.01%
486
-58
-11% -$11.3K
SHCO
990
DELISTED
Soho House & Co
SHCO
$108K ﹤0.01%
15,100
-4,100
-21% -$28.9K
OPI
991
DELISTED
Office Properties Income Trust
OPI
$107K ﹤0.01%
14,550
-304
-2% -$1.62K
DNA icon
992
Ginkgo Bioworks
DNA
$498M
$106K ﹤0.01%
1,574
+385
+32% +$23.6K
LAZR
993
DELISTED
Luminar Technologies
LAZR
$106K ﹤0.01%
2,106
+1,265
+150% +$62.9K
MEDP icon
994
Medpace
MEDP
$16.3B
$105K ﹤0.01%
345
+235
+214% +$63.4K
ALLO icon
995
Allogene Therapeutics
ALLO
$625M
$104K ﹤0.01%
32,498
+17,471
+116% +$49.6K
CTO
996
CTO Realty Growth
CTO
$756M
$104K ﹤0.01%
6,017
-42
-0.7% -$699
LRN icon
997
Stride
LRN
$4.16B
$104K ﹤0.01%
1,760
+215
+14% +$11.8K
OLP
998
One Liberty Properties
OLP
$542M
$104K ﹤0.01%
4,729
-104
-2% -$2.07K
SOFI icon
999
SoFi Technologies
SOFI
$19.6B
$103K ﹤0.01%
+10,371
New +$82.4K
FSR
1000
DELISTED
Fisker Inc.
FSR
$102K ﹤0.01%
58,032
+44,337
+324% +$157K

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.